Understand the funding process for KAPRUVIA® (difelikefalin)
Overview
Watch this video, where Dr Keiran McCafferty explains how KAPRUVIA® is funded by NHS England and provides guidance on the Blueteq process
This webinar is CPD accredited.
Download the certificate here once you have completed ALL chapters
Prescribing information and adverse event reporting information:
- Kapruvia®▼(difelikefalin): Click here
UK-DFK-2400103 (V3.0) | August 2025
Adverse events should be reported. Reporting forms and information for the United Kingdom can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Fresenius Medical Care Renal Pharma, care of Vifor Pharma Ltd.
Tel: +44 1276 853633. E-mail: MedicalInfo_UK@viforpharma.com.
